Manufacturer record
Adison Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Adison Pharmaceuticals (Punjab) was declared Not of Standard Quality in July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 17253, Diclofenac Sodium & Paracetamol Tablets. (Diclopat-Plus) (exp Sep 2026). State Drugs Laboratory, Punjab (state lab) found it not of standard quality: The Product is official in I.P 2022 but it is not mentioned anywhere on the Product label. Listed in the July 2025 alert.
Records by type
1 record linked to Adison Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium & Paracetamol Tablets. (Diclopat-Plus) | Batch 17253Mfg Oct 2024 · Exp Sep 2026 | The Product is official in I.P 2022 but it is not mentioned anywhere on the Product label.Labelling | State Drugs Laboratory, PunjabState lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.